Page 3 - Michael Abrams News Today

Caribbean box jellyfish, animals that may appear to float through life aimlessly and don’t have a central brain, still have the ability to learn rapidly and retain information, new research has found.

FRAMINGHAM, Mass., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today

Common Stock Listing on National Exchange is Next Planned Significant Milestone...

Industry Entertainment co-founder is set to launch a new venture and he and former Industry colleague Michael Abrams are set to launch Constellation Media…

Last week, the CFO of Universal Health Services stated that the company chooses which patients to treat based on whose insurance plans offer the highest payments. The comments have sparked some media attention, but healthcare finance experts say the practice of cherry-picking patients is nothing new to the industry.

The FDA limited the approval of Sarepta Therapeutics’ treatment to patients ages 4 to 5 years old who still have the ability to walk.

Animals have been catching z’s for at least half a billion years. Here’s the first evidence of an animal sleeping

An advisory panel for the US Food and Drug Administration voted unanimously Friday that the Alzheimers drug lecanemab shows "clinical benefit" for the treatment of the disease, paving the way

(CNN) — An advisory panel for the US Food and Drug Administration voted unanimously Friday that the Alzheimer’s drug lecanemab shows “clinical benefit” for the treatment of the disease, paving

(CNN) — An advisory panel for the US Food and Drug Administration voted unanimously Friday that the Alzheimer’s drug lecanemab shows “clinical benefit” for the treatment of the disease, paving